openPR Logo
Press release

Global Dermatological Products Market Expected to Deliver Dynamic Progression until 2028 | Major Players - Ikeda Mohando , Johnson & Johnson Consumer , Taisho Pharmaceutical , Bayer AG , Glaxo SmithKline , Merck & Co. Inc , Perrigo Company , Emami

12-05-2018 08:47 AM CET | Industry, Real Estate & Construction

Press release from: Fact.MR

Global Dermatological Products Market Expected to Deliver

The dermatological products market is likely to grow at a steady pace in the long run, as per the latest report by Fact.MR. The demand for dermatological products continue to remain influenced with new formulations developed by manufacturers to treat various skin conditions and diseases.

The demand for dermo-cosmetic products combining OTC and prescription products to treat acne, skin infections, atopic dermatitis and other skin conditions is also increasing. Fact.MR estimates that the sales of dermatological products is expected to surpass US$ 13,000 million by the end of 2018.

The demand for dermatological products is likely to be the highest among female consumers. Owing to the increasing skin diseases such as acne, rosacea, skin cancer, in women the maximum demand in dermatological products market is from female customers. The demand for dermo-cosmetic products is also rising among women. Also, over-the-counter anti-aging dermatological products are gaining popularity among female consumers.

Request 100 Page Sample Report Now: https://www.factmr.com/connectus/sample?flag=S&rep_id=2363

Demand for Dermatological Products to Remain High in North America

North America is expected to witness significant growth in the demand and sales of dermatological products in 2018. Growing number of skin diseases across all age groups in the US is likely to create growth opportunities for manufacturers in the dermatological products market in the region.

According to the American Academy of Dermatology, acne is the most common skin condition in the US, affecting around 50 million people every year. Moreover, nearly 7.5 million people in the US suffer from psoriasis. Majority of dermatological products treating acne, psoriasis, and other skin conditions have been approved by Food and Drug Administration (FDA) in last few years, while many dermatological products are still under process of approval.   

In Canada, UV exposure is emerging as the growing risk resulting in melanoma as fastest rising cancers. According to the research by Canadian Dermatology Association (CDA), use of sunscreen continues to rise in Canada. In 2017, among 15-29 years of age group, around 7% of new melanoma cancer cases were registered in Canada.

Canadian consumers are also moving towards adopting premium skin care dermatological products with high quality of natural ingredients. Dermatological products including facial oils, masks, and serums are gaining immense popularity among consumers in Canada.

Request Full Report With TOC: https://www.factmr.com/report/2363/dermatological-products-market

Acne Treatment Products to Witness Surge in Demand

Demand for acne treatment dermatological products is projected to witness robust growth in the coming years. Increasing cases of acne worldwide, coupled with innovation in acne treatment is expected to drive demand for acne treatment products. Increasing research activities along with better understanding of pathology of acne is likely to result in new and safer acne treatment products by manufacturers in the dermatological products market.

Targeting inflammatory mechanisms with disease modifying ability, biologics is finding large application in development of acne treatment products. Acne is affecting increasing number of adolescents and young adults. According to the American Academy of Dermatology, acne is increasing among women, affecting nearly 15% of women in the US.

Currently, topical drugs or topical therapy are widely used by increasing number of people in acne treatment across the world. As per the study by Fact.MR, acne treatment products are expected to bring in more than US$ 3,000 million by 2018 end. Meanwhile, scar and stretch mark products are also likely to witness increasing demand in the dermatological products market owing to rise in accidents, surgeries, and rise in consciousness among pregnant women on developing stretch marks.

The overall growth in the dermatological products market is likely to remain steady. The demand in the dermatological products market is expected to reach 3.7% CAGR during 2018-2027.

Ask Industry Expert about this Report - https://www.factmr.com/connectus/sample?flag=AE&rep_id=2363

About Fact.MR

Fact.MR is a fast-growing market research firm that offers the most comprehensive suite of syndicated and customized market research reports. We believe transformative intelligence can educate and inspire businesses to make smarter decisions. We know the limitations of the one-size-fits-all approach; that's why we publish multi-industry global, regional, and country-specific research reports.

Contact Us
Fact.MR
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Email: sales@factmr.com
Web: https://www.factmr.com/
Blog: https://factmrblog.com/
Read Industry News at - https://www.industrynewsanalysis.com/

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Global Dermatological Products Market Expected to Deliver Dynamic Progression until 2028 | Major Players - Ikeda Mohando , Johnson & Johnson Consumer , Taisho Pharmaceutical , Bayer AG , Glaxo SmithKline , Merck & Co. Inc , Perrigo Company , Emami here

News-ID: 1417937 • Views:

More Releases from Fact.MR

Craft Beer Market is forecasted to reach a value of US$ 174.68 Billion by 2032
04-24-2024 | Food & Beverage
Fact.MR
Craft Beer Market is forecasted to reach a value of US$ 174.68 Billion by 2032
The worldwide craft beer market was expected to be worth $76.3 billion in 2020 and $81.64 billion in 2021. The market will grow at a steady CAGR of 6.9% between 2022 and 2032. By the end of 2032, this market is predicted to have a global valuation of US$174.68 billion. The surge in demand for more beer styles coupled with increase in per capita income among the target customers has triggered
Window Blinds Market Forecasted to Achieve US$ 4.69 Billion by 2034
Window Blinds Market Forecasted to Achieve US$ 4.69 Billion by 2034
The global window blinds market is expected to reach $2.99 billion in 2024, growing at a 5.8% CAGR to $4.69 billion by the end of 2034. Window blinds are adjustable window coverings made of slats or vanes, allowing for versatile control over light and privacy. They come in various materials, including wood, metal, or plastic, and can be easily adjusted to regulate sunlight and maintain privacy. Unlike heavy curtains, blinds are
Vacuum Salt Market is Expected to reach 12,765.2 Million by 2034
04-24-2024 | Food & Beverage
Fact.MR
Vacuum Salt Market is Expected to reach 12,765.2 Million by 2034
The global vacuum salt market is expected to be worth US$ 8,012.3 million in 2024. Projections show a steady expansion with a 4.8% CAGR through 2034. The market is anticipated to be valued at $12,765.2 million by 2034. Growing consumer preference for the ingredient's use in the production of food, as vacuum salt is essential to create a balanced diet, is the factor driving the growth of the global market. The
Hemoglobinopathy Market Forecast Growing at 8.3% CAGR to Reach $1.7 Billion by 2034
04-24-2024 | Health & Medicine
Fact.MR
Hemoglobinopathy Market Forecast Growing at 8.3% CAGR to Reach $1.7 Billion by 2 …
In 2024, the global hemoglobinopathy market (ヘモグロビン症市場) is estimated to be worth US$788.1 million, with a projected compound annual growth rate (CAGR) of 8.3% through 2034. By 2034, the market size is expected to exceed US$1,745.7 million. The rise of genetic testing has led to a significant shift in the hemoglobinopathy market towards personalized medication. Companies are leveraging this trend to develop tailored treatment plans based on each patient's DNA

All 5 Releases


More Releases for Dermatological

Dermatological Drugs Market : Competitive Dynamics & Global Outlook 2031
Dermatological drugs Market - Overview The growth opportunities in the dermatological drugs market are growing at a noticeable speed due to numerous factors. Amongst these key factors, are the fungus, parasites, and some other microorganisms that are living on the skin. The bacteria are generally trapped in hair follicles and skin pores hold numerous fluids and prevent dehydration. These factors are estimated to fuel novel revenue generation opportunities in the market
Dermatological Drugs Market 2021: Global Industry Analysis Report to 2027
The global dermatological drugs market is anticipated to grow at a significant CAGR during the forecast period (2021-2027). Dermatology is a field of medicine that is engaged in the diagnosis, prevention, and treatment of various diseases related to skin, nails, and hair, such as pigmentation, acne, wrinkles, and psoriasis. Dermatological agents, also known as dermatological, are products that are applied topically on the skin. These products are used to treat
Dermatological Drugs Market Report 2021-2031 - newly published
This new report will cover these areas: Forecasts by Disease (Psoriasis, Dermatitis, Acne, Skin Infections, Other Diseases), by Skin Infections Drugs (Bepanthen/Bepanthol, Protopic, Dermovate), by Psoriasis Drugs (Humira, Stelara, Enbrel, Remicade, Taltz, Otezla), by Dermatitis Drugs (Cubicin, Zyvox, Valtrex, Canesten, Lamisil, Other Dermatitis Drugs), by Route of Administration (Topical, Oral, Parenteral Administration) AND Regional and Leading National Market Analysis PLUS Analysis of Leading Dermatological Drugs Companies AND COVID-19 Recovery Scenarios. What
Newly Released Visiongain Report: Dermatological Drugs Market Forecast 2020-2030
Psoriasis, Skin Infection, Acne, Dermatitis, Others To find out more about this report, click the link: https://www.visiongain.com/report/dermatological-drugs-market-forecast-2020-2030/ The revenue of the dermatological drugs market in 2018 is estimated at $31bn and is expected to grow at a CAGR of 3.7% in the first half of the forecast period. Psoriasis drugs segment accounted for the largest share of the market in 2018, this segment accounted for 38% of the global dermatological drugs market. How this
Dermatological Disorders Medications Market Size, Share, Development by 2024
New report published by Global Info Research which offers insights on the Global Dermatological Disorders Medications market. Dermatology diseases includes common skin rashes to severe skin infections, which occurs due to range of things, such as infections, heat, allergens, system disorders and medications. Click to view the full report TOC, figure and tables: https://www.globalinforesearch.com/global-dermatological-disorders-medications-market_p103576.html Global Dermatological Disorders Medications Market: Forecast by Type / Application / Region The worldwide market for Dermatological Disorders Medications is
Global Dermatological Devices Market
The Global Dermatological Devices Market was valued at US$ 6,565.5 million in 2015 and is projected to expand at a CAGR of 7.6% during the forecast period (2016–2024),as highlighted in a new report published by Coherent Market Insights.Rise in number of patients suffering from non-melanoma and melanoma skin cancers is expected to be one of the major factor to drive the dermatology devices market in the near future. According to